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Abstract: 
We examined the potential of antibody-functionalized single-walled carbon nanotube 
(SWNT) field-effect transistors (FETs) for use as a fast and accurate sensor for a Lyme 
disease antigen.  Biosensors were fabricated on oxidized silicon wafers using chemical 
vapor deposition grown carbon nanotubes that were functionalized using diazonium salts.  
Attachment of Borrelia burgdorferi (Lyme) flagellar antibodies to the nanotubes was 
verified by Atomic Force Microscopy and electronic measurements.  A reproducible shift in 
the turn-off voltage of the semiconducting SWNT FETs was seen upon incubation with 
Borrelia burgdorferi flagellar antigen, indicative of the nanotube FET being locally gated by 
the residues of flagellar protein bound to the antibody.  This sensor effectively detected 
antigen in buffer at concentrations as low as 1 ng/ml, and the response varied strongly 
over a concentration range coinciding with levels of clinical interest.  Generalizable binding 
chemistry gives this biosensing platform the potential to be expanded to monitor other 
relevant antigens, enabling a multiple vector sensor for Lyme disease.  The speed and 
sensitivity of this biosensor make it an ideal candidate for development as a medical 
diagnostic test. 
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1. Introduction 
 
 Lyme disease is a tick-borne illness caused by the bacteria Borrelia burgdorferi, 
generating at least 30,000 new cases in the United States each year, although there are 
likely many more cases that go undetected or misdiagnosed due to generality of symptoms 
(Centers for Disease Control and Prevention 2011).  Of the patients diagnosed with Lyme 
disease, many are originally misdiagnosed due to the general symptoms of the disease 
(Williams et al. 1990), inconsistent disease presentation in patients (Aguerorosenfeld et al. 
1993), and lack of sensitive testing available for early stages of the infection (Bakken et al. 
1997).  Late detection of Lyme disease can result in further complications including 
arthritis and permanent neurological disorders (Marques 2008). Diagnosis of Lyme disease 
is severely hindered by the lack of reliable diagnostic tools despite its importance to 
treatment success (Murray and Shapiro 2010; O'Connell 2010). A reliable and rapid 
laboratory diagnostic tool is crucial to reducing the number of misdiagnosed patients and 
for investigating appropriate treatment protocols for chronic Lyme disease. 
 In recent years, great progress has been made in the field of carbon nanotube field 
effect transistor (CNT FET)-based biosensors (Allen et al. 2007).  Benefits of nanotube-
based sensors include the speed and reliability obtained from performing multiple assays 
in parallel (Chikkaveeraiah et al. 2009).  Protein-functionalized nanotube-based FETs are of 
great research and clinical interest for several reasons.  Their nanometer size is 
comparable to the size of many biomolecules of interest, suggesting a unique biocompatible 
platform (Harrison and Atala 2007; Lerner et al. 2011; Sudibya et al. 2009).  Additionally, 
since every atom of a carbon nanotube is located on its surface, in direct contact with the 
environment, they are a clear choice for direct environmental sensing. Commercially 
available assays for Lyme-specific antigens in urine and cerebrospinal fluid have a limit of 
detection of 12-15 ng/mL (Shah et al. 2004). We hypothesized that an antibody-
functionalized SWNT FET immunosensor would be able to detect the small amount of Lyme 
antigen that is present in bodily fluids at very early stages of Borrelia infection (Harris and 
Stephens 1995) since protein-functionalized nano-enabled sensors have demonstrated 
very low detection limits, on the order of fM (Duan et al. 2012; Lerner et al. 2012a). Direct 
detection of the antigen provides earlier test results because it eliminates the delay 
required for the immune system to produce sufficient quantities of antibodies to be 
detected via Western Blot or ELISA, which can improve patient prognosis (Ma et al. 1992). 
Here we demonstrate that antibody-functionalized SWNT FET devices are effective 
biosensors for rapidly detecting Lyme flagellar antigen at clinically relevant concentrations, 
as low as 1 ng/ml, with negligible response to negative-control proteins and to pure buffer 
solution.   
  
2. Materials and Methods 
  
2.1 Device Fabrication: 
 
Carbon nanotube transistors were fabricated using previously described methods (Khamis 
et al. 2011). Briefly, a solution of Iron (III) Nitrate dissolved in isopropanol was spin coated 
onto a p++ doped Si/SiO2 wafer to give an iron catalyst layer. Single-walled nanotubes were 
grown by catalytic chemical vapor deposition (CVD) with methane (2500 sccm) as the 
carbon source in a background of forming gas (600 sccm Ar, 320 sccm H2) at 900°C for 2 
mins. Following the growth, an optimized bilayer photolithography process using PMGI 
and Shipley 1813 was used to pattern source and drain electrodes with 2.5 um channel 
length that were subsequently metallized (3 nm Ti/40 nm Pd) using  thermal evaporation.  
The doped silicon substrate served as a global backgate to complete the three terminal 
field-effect transistor geometry. Devices were individually characterized by sweeping the 
back gate voltage from -10 V to 10 V while holding the bias voltage fixed at 100 mV.  
Approximately 80 high quality semiconducting SWNT devices with ON/OFF ratios >1000 
were selected for use in experiments.   
 
2.2 Protein functionalization 
 
Monoclonal Lyme antibodies specific for Borrelia Burgdorferi flagellar antigen (p41) were 
obtained commercially (antibodies-online.com).  Histidine-tagged Lyme antigen containing 
the p41 flagellar immunodominant region (also known as flagellin) was obtained from 
ProSpec. Antigen was diluted with Tris-HCl buffer (pH 7.5), aliquoted to several 
concentrations and stored at 4° C.  Antibodies were aliquoted at a concentration of 1 μg/ml 
in Tris-HCl buffer and stored at -20° C.   
 
Nanotube functionalization followed previously documented procedures (Lerner et al. 
2012a) adapted from (Strano et al. 2003) (see Figure 1). Carbon nanotubes were 
functionalized using diazonium salts synthesized according to a published recipe (Saby et 
al. 1997). Samples were immersed in a solution of 4-carboxybenzene diazonium 
tetrafluoroborate at a concentration of 2.5 mg/1 mL deionized (DI) water for 1 hr at 40°C 
to create sp3 hybridization sites ending in carboxylic acid groups, then rinsed for 1 min 
each in acetone, methanol, and deionized water baths. The carboxylic acid groups were 
then activated with EDC and stabilized with sulfo-NHS at concentrations of 6 mg and 16 mg 
per 15 mL MES buffer (pH 6.0) respectively for 15 minutes at room temperature, followed 
by a DI water rinse.  A solution of antibodies at a concentration of 1 μg/mL was pipetted 
onto the nanotube devices in a humid environment to prevent the solution from 
evaporating, causing primary amines on the antibody to displace stabilized sulfo-NHS sites 
over a period of one hour.  The devices were washed thoroughly by rinsing in two DI water 
baths for 2 mins each and dried with gentle (less than 20 psi) nitrogen flow in order to 
minimize the amount of salts and non-specifically bound proteins on the device.  
 
 
Figure 1 Functionalization chemistry for Lyme antibody and binding of flagellar antigen. First, a pristine 
nanotube is treated with diazonium salts to create sp3 hybridization sites ending in carboxylic acid moieties. The 
carboxylic acid is activated with EDC and stabilized with sulfo-NHS. The sulfo-NHS is displaced by the primary 
amine in a surface lysine residue (depicted in red) on the anti-p41 antibody. The flagellar antigen (depicted 
according to secondary structure in purple, cyan, and yellow) then binds to the epitope on the antibody during 
the exposure step.  
Antibody-functionalized SWNT-FET devices were similarly exposed to droplets of antigen 
at a known concentration for 20 minutes in a humid environment to prevent the droplet 
from evaporating. Exposure to Lyme flagellar antigen occurred over a sufficiently long time 
scale to ensure adequate time for the proteins to diffuse to the sensor and establish 
equilibrium between bound and unbound species. This is known to be a critical 
consideration for detection of biomolecular analytes at pM or lower concentration (Squires 
et al. 2008). The devices were then washed in two DI water baths for 2 mins each to 
remove non-specifically bound antigen and dried with gentle nitrogen flow. Each device 
was exposed to only one concentration of antigen in order to avoid contamination of 
samples, and each concentration of antigen was tested on 5-10 functionalized devices to 
ensure reproducibility of the results.  
 
3. Results and Discussion 
 
In order to verify the validity of the attachment chemistry, Atomic Force Microscopy (AFM) 
data were gathered on an Asylum AFM in tapping mode following both antibody 
attachment and exposure to antigen. Figure 2a-b are AFM images that show the 
effectiveness of the functionalization procedure, which results in 3-5 attachment sites per 
micrometer of nanotube length. Statistical analysis shows that the antibodies are 2.78 nm ± 
0.22 nm in size, slightly smaller than expected for a complete IgG. This is likely due to the 
protein being slightly distorted during tapping mode AFM in air. We conducted a control 
experiment to establish that nanotubes and the nanotube/SiO2 interface show very low 
affinity for nonspecific binding of the Lyme antigen; details are provided in Supplementary 
Materials Figure S1. When exposed to 1 µg/mL Lyme antigen, there was minimal non-
specific binding to the nanotubes or the surrounding substrate. 
 
 
Figure 2 a) AFM image of anti-p41 antibody proteins attached to carbon nanotubes. Z scale is 6 nm, average 
protein feature is ~2.8 nm in size. b) AFM image after incubation in a solution of FLA antigen at a concentration of 
400 ng/mL shows antigen attached to bound antibodies on a nanotube. Z scale is 8 nm . c) Histogram of feature 
heights following antibody attachment (red data) and exposure to antigen (black data).   
 
After exposure to flagellar antigen at a concentration of 400 ng/mL, the histogram of 
feature heights shows a shift towards larger proteins complexes. There are two main peaks 
at feature height of 4.7 ± 0.6 nm and 6.5 ± 0.4 nm. These are associated with binding of one 
and two antigen proteins, respectively, to a bound antibody, consistent with the fact that 
the IgG used in the experiments has two binding sites (Talwar and Srivastava 2006). Each 
added antigen increases the feature height by approximately 1.8 nm. There also appears to 
be an additional peak at ~3 nm that represents unreacted antibodies; this peak accounts 
for ~20% of the total features measured. These data suggest that after exposure to antigen 
at 400 ng/mL, approximately 80% of the antibodies have bound at least one antigen, in 
good agreement with the electronic response data presented in Figure 3b, below. 
 
Electronic measurements of the current as a function of the backgate voltage (I-Vg 
characteristics) for individual NT FET devices were taken following each chemical 
modification to monitor the effect of chemical functionalization and to confirm attachment 
of antibodies (Figure 3a). Parameters of interest included ION, the ON state current of the 
device, and VTH, the threshold voltage, where the line tangent to the I-Vg curve intersects 
the gate voltage axis. A 50-90% drop in ION as well as a 3-4 V decrease in the threshold 
voltage resulted from diazonium oxidation, which is associated with the creation of sp3 
hybridization sites terminated with a carboxylic acid group.  EDC/NHS treatment resulted 
in a slight decrease in the ON state current and no statistically significant shift in the 
threshold voltage. Following antibody attachment, there was typically an increase in ON 
state current, suggesting that attachment led to a decrease in carrier scattering. Upon 
antigen exposure, a shift in the threshold voltage towards more negative values was 
consistently observed. There was no statistically significant change in ON state current 
following antigen exposure.   
 
Figure 3 a) Current vs. Gate Voltage characteristics at subsequent stages of nanotube functionalization. The 
sensing response is the 2.3 V decrease of the threshold voltage upon exposure to antigen (green to purple curves). 
b) Threshold voltage shift as a function of antigen concentration can be fit with a model based on the Hill-
Langmuir equation. These data indicate a limit of detection of ~ 1 ng/mL and non-cooperative antigen binding . 
Inset shows structure of anti-p41 Borrelia antibody with lysine (red), histidine (orange) and arginine (green) 
residues highlighted. Any of these basic residues could become protonated and generate a local gating effect if 
they come into closer contact with the nanotube upon antigen binding. 
There was a systematic dependence of the threshold voltage shift with varying antigen 
concentration in the range 0.1 ng/ml to 3 µg/ml, with each concentration tested on 5-10 
functionalized devices. The variation of the average measured shift in the threshold voltage 
as a function of antigen concentration is displayed in Figure 3b. Error bars shown are the 
standard error of the mean. The sensor responses agree with a model based on the Hill-
Langmuir equation for equilibrium protein binding (see Figure 3b) (Hill 1910; Lehninger et 
al. 2008). 
 
 
 
 
Here c is the Lyme antigen concentration, A is the sensor response at saturation when all 
binding sites are occupied, Z is an overall offset to account for the response to pure buffer, 
Kd is the dissociation constant describing the concentration at which half of available 
binding sites are occupied, and n is the Hill coefficient describing cooperativity of binding.  
 
The best fit to the data yielded a maximum response A = -2.52 V ± 0.32 V, offset parameter 
Z = -0.12 V ± 0.16 V, dissociation constant Kd = 87 ng/mL ±27 ng/mL, and n = 1.04 ± 0.08. 
The best fit value of the offset parameter Z = -0.12 V ± 0.16 V was statistically 
indistinguishable from the experimentally measured responses of seven devices to pure 
buffer as a negative control (ΔV=0.11 V ± 0.15 V). The value of Kd = 87 ± 27 ng/mL 
determined from the fit describes the concentration of antigen at which half the receptors 
are occupied; this regime coincides with antigen levels of diagnostic significance, 12-15 
ng/mL (Shah et al. 2004). It is notable that the AFM image in Figure 2, taken after exposure 
to antigen at 400 ng/mL, showed occupation of at ~80% of the attached antibody sites, in 
good agreement with the prediction of the Hill-Langmuir fit that 95% of the active sites 
were occupied at this concentration. The slight discrepancy could be due to antibodies that 
were bound to the nanotube in such an orientation that their epitope is obstructed or were 
otherwise non-functional. The Hill-Langmuir model combined with the AFM data suggested 
that the number of such antibodies unavailable for binding is no more than 20% of the total 
bound antibodies. 
 
The best fit value of the cooperativity parameter, n = 1.04 ± 0.08, indicates independent 
binding of Lyme antigen to the anti-p41 in the context of the NT-FET biosensor. The data 
presented in Figure 3b show that the measured responses from a collection of 5-10 devices 
could be used to differentiate between pure buffer solution (ΔV = 0.11 V ± 0.15 V) and 
buffer containing Lyme antigen at a concentration of at a concentration of 1 ng/mL (ΔV = -
0.31 V ± 0.24 V). Previous work suggests that this limit of detection may be lowered by as 
much as a factor of 1000 by replacing the complete IgG with its single chain variable 
fragment, thus allowing the binding event to occur closer to the nanotube where the 
electrostatic influence on transport in the NT transistor will be more pronounced (Lerner 
et al. 2012a).  
 
The observed reduction in turnoff voltage is consistent with a gating effect due to the 
presence of positive charges in the local electrostatic environment of the carbon nanotube 
(Heller et al. 2008). The proposed mechanism responsible for introducing these positive 
local charges is a conformational change in the antibody protein upon binding the flagellar 
antigen, which results in the carbon nanotube being exposed to different amino acids on 
the antibody exterior. Charges in close proximity to carbon nanotubes have been shown to 
shift the transistor threshold voltage by local gating (Lerner et al. 2012b). Lysine, histidine, 
and arginine (highlighted in the inset of Figure 3b) are common amino acids, a portion of 
which will be protonated when the pH is less than 7 and could thus be candidates for 
locally gating the nanotube as observed. Experimental conditions may be as low as pH 5 
due to deprotonation of silanol groups in a thin water layer that forms on the hydrophilic 
SiO2 surface (O'Reilly et al. 2005). Even in the absence of a quantitative understanding of 
the device response, the results provide strong evidence that the methods used here 
enabled attachment of antibody proteins to a NT-FET while maintaining both the high 
quality electronic characteristics of the NT device and the chemical recognition 
functionality characteristic of the protein. 
 
As a further control experiment, antibody-functionalized sensors were incubated in a 
solution of bovine serum albumin (BSA) at high concentration (1 μg/mL) to approximate 
the effect of non-specific proteins present in patient samples (human serum albumin is a 
large component of blood plasma proteins and represents a potential interfering agent 
(Peters 1996)). A sample I-Vg characteristic is presented in Supplementary Materials Figure 
S2. The sensor response to BSA, averaged over eight devices, was a shift of -0.13 V ± 0.18 V, 
similar to the response produced by buffer alone. We thus concluded that the Lyme 
flagellar antibody-functionalized carbon nanotube transistors exhibited a high level of 
specificity for the flagellar protein target antigen.  
 
    
4. Conclusions 
 We demonstrated that antibody-functionalized SWNT FET devices are effective 
biosensors for rapidly detecting Lyme disease antigen at diagnostically relevant 
concentrations. The sensor shows a decrease in the threshold voltage in minutes rather 
than days, as required for a traditional clinical assay. We achieved detection of flagellar 
antigen protein at a concentration of 1 ng/ml with negligible response to control proteins 
and to pure buffer solution. The experiments showed an antigen-specific, concentration-
dependent sensor response over a wide range of concentrations (1 ng/mL to 3000 ng/mL) 
that was in excellent quantitative agreement with a model based on the Hill-Langmuir 
equation of equilibrium thermodynamics. Future work includes functionalizing samples 
with single chain variable fragments to increase sensitivity and the use of a sensor array 
based on multiple antibodies in order to capture several types of proteins indicative of 
Lyme disease for a multiplexed biosensor platform. The rapidity and ease of use of this 
sensor is superior to traditional immunoassays, suggesting its utility as a point-of-care 
diagnostic tool. 
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